Asia Pacific Cerebrospinal Fluid Management Market Forecast to 2030
Asia Pacific Cerebrospinal Fluid Management Market Forecast to 2030 – Regional Analysis – by Product (CSF Shunts and CSF Drainage Systems) and End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others)
$2,485 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Focus on CSF Management in Neurological Disease Treatments Fuels the Asia Pacific Cerebrospinal Fluid Management Market
CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson’s Disease (PD), Alzheimer’s Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer’s disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer’s disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.
Asia Pacific Cerebrospinal Fluid Management Market Overview
The Asia Pacific cerebrospinal fluid management is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Asia Pacific is the fastest-growing market for cerebrospinal fluid management in global scenario. The cerebrospinal fluid management market growth in this region is attributed to growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.
Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Asia Pacific Cerebrospinal Fluid Management Market Segmentation
The Asia Pacific cerebrospinal fluid management market is segmented into product, end user and country.
Based on product, the Asia Pacific cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held a larger market share in 2022.
Based on end user, the Asia Pacific cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest market share in 2022.
Based on country, the Asia Pacific cerebrospinal fluid management market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific cerebrospinal fluid management market share in 2022.
B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, and Spiegelberg GmbH & Co KG are some of the leading companies operating in the Asia Pacific cerebrospinal fluid management market.
Summary Info
| Industry: | |
|---|---|
| Pricing options: | |
| Publishing status: | |
| Geographical coverage: | |
| Year of Publication: |
According to The Research Team’ research, the Asia Pacific cerebrospinal fluid management market was valued at US$ 389.53 million in 2022 and is expected to reach US$ 613.54 million by 2030, registering a CAGR of 5.8% from 2022 to 2030. Government initiatives for addressing growing challenges associated with CSF is among the critical factors attributed to the Asia Pacific cerebrospinal fluid management market expansion.
Across the region, governments are taking comprehensive steps to enhance the quality of healthcare services provided to those in need of CSF management. These initiatives vary in nature but share a common goal: to improve patient access, early diagnosis, and the quality of care. For instance, Japan’s universal health insurance system ensures that its citizens have access to essential health services, including neurological care and CSF management. Also, India allocates government funding to support research on neurodegenerative diseases and CSF disorders. Further, in Australia, community awareness campaigns work to reduce stigma and improve understanding of neurological disorders. Governments are also investing in healthcare infrastructure, such as specialized neurology centers and telemedicine networks, to increase access to neurological expertise, particularly in remote areas. Singapore’s National Neuroscience Institute (NNI) is an example of infrastructure development, while Malaysia has been implementing telemedicine solutions for neurology consultations. Moreover, policy frameworks and clinical guidelines in countries such as South Korea standardize the diagnosis and management of neurological conditions. Such government initiatives are instrumental in ensuring that patients receive proper care, promoting early detection, and advancing the quality of CSF management across the Asia Pacific region.
On the contrary, risk of failure and malfunctioning hampers on the growth of Asia Pacific cerebrospinal fluid management market.
Based on product, the Asia Pacific cerebrospinal fluid management market is bifurcated into CSF shunts and CSF drainage systems. The CSF shunts segment held 88.2% share of Asia Pacific cerebrospinal fluid management market in 2022, amassing US$ 343.58 million. It is projected to garner US$ 548.90 million by 2030 to expand at 6.0% CAGR during 2022–2030.
Based on end user, the Asia Pacific cerebrospinal fluid management market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held 56.1% share of Asia Pacific cerebrospinal fluid management market in 2022, amassing US$ 218.38 million. It is projected to garner US$ 352.85 million by 2030 to expand at 6.2% CAGR during 2022–2030.
Based on country, the Asia Pacific cerebrospinal fluid management market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 29.5% share of Asia Pacific cerebrospinal fluid management market in 2022. It was assessed at US$ 115.06 million in 2022 and is likely to hit US$ 191.59 million by 2030, exhibiting a CAGR of 6.6% during 2022–2030.
Key players operating in the Asia Pacific cerebrospinal fluid management market are B. Braun SE, Integra LifeSciences Holdings Corp, Medtronic Plc, Natus Medical Inc, and Spiegelberg GmbH & Co KG, among others.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific cerebrospinal fluid management market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific cerebrospinal fluid management market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Cerebrospinal Fluid Management Market Landscape
4.1 Overview
4.2 Asia Pacific PEST Analysis
5. Asia Pacific Cerebrospinal Fluid Management Market – Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Cases of Cerebrospinal Fluid Leaks
5.1.2 Government Initiatives for Addressing Growing Challenges Associated with CSF
5.2 Market Restraints
5.2.1 Risk of Failure and Malfunctioning
5.3 Market Opportunities
5.3.1 Increasing Focus on CSF Management in Neurological Disease Treatments
5.4 Future Trends
5.4.1 Development of Smart Cerebrospinal Fluid Shunts
5.5 Impact Analysis:
6. Cerebrospinal Fluid Management Market – Asia Pacific Market Analysis
6.1 Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
7. Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by Product
7.1 Overview
7.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
7.3 CSF Shunts
7.3.1 Overview
7.3.2 CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.3 Ventriculoperitoneal Shunts
7.3.3.1 Overview
7.3.3.2 Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.4 Ventriculoatrial Shunts
7.3.4.1 Overview
7.3.4.2 Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.5 Ventriculopleural Shunts
7.3.5.1 Overview
7.3.5.2 Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.3.6 Lumboperitoneal Shunts
7.3.6.1 Overview
7.3.6.2 Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4 CSF Drainage Systems
7.4.1 Overview
7.4.2 CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.3 External Ventricular Drainage (EVD) Systems
7.4.3.1 Overview
7.4.3.2 External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
7.4.4 Lumbar Drainage (LD) Systems
7.4.4.1 Overview
7.4.4.2 Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 – by End User
8.1 Overview
8.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Clinics
8.4.1 Overview
8.4.2 Clinics: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Ambulatory Surgical Centers
8.5.1 Overview
8.5.2 Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Cerebrospinal Fluid Management Market – Country Analysis
9.1 Overview
9.1.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by Country
9.1.1.2 China
9.1.1.2.1 Overview
9.1.1.2.2 China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.2.3 China: Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.1.1.2.3.1 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.2.3.2 China: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.2.4 China: Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.1.1.3 Japan
9.1.1.3.1 Overview
9.1.1.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.3.3 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.1.1.3.3.1 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.3.3.2 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.3.4 Japan: Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.1.1.4 India
9.1.1.4.1 Overview
9.1.1.4.2 India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.4.3 India: Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.1.1.4.3.1 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.4.3.2 India: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.4.4 India: Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.1.1.5 Australia
9.1.1.5.1 Overview
9.1.1.5.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.5.3 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.1.1.5.3.1 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.5.3.2 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.5.4 Australia: Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.1.1.6 South Korea
9.1.1.6.1 Overview
9.1.1.6.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.6.3 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.1.1.6.3.1 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.6.3.2 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.6.4 South Korea: Asia Pacific Cerebrospinal Fluid Management Market, by End User
9.1.1.7 Rest of Asia Pacific
9.1.1.7.1 Overview
9.1.1.7.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
9.1.1.7.3 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by Product
9.1.1.7.3.1 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
9.1.1.7.3.2 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
9.1.1.7.4 Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market, by End User
10. Asia Pacific Cerebrospinal Fluid Management Market –Industry Landscape
10.1 Overview
10.2 Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Medtronic Plc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Integra LifeSciences Holdings Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 B. Braun SE
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Natus Medical Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Spiegelberg GmbH & Co KG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation
Table 2. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 3. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 4. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 5. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 6. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 7. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 8. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 9. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 10. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 11. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 12. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 13. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 14. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 15. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 16. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 17. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 18. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 19. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 20. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 21. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 22. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – Product
Table 23. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Shunts
Table 24. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – CSF Drainage Systems
Table 25. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) – End User
Table 26. Recent Inorganic Growth Strategies in the Asia Pacific Cerebrospinal Fluid Management Market
Table 27. Recent Organic Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market
Table 28. Glossary of Terms, Asia Pacific Cerebrospinal Fluid Management Market
LIST OF FIGURES
Figure 1. Asia Pacific Cerebrospinal Fluid Management Market Segmentation, By Country
Figure 2. Asia Pacific – PEST Analysis
Figure 3. Asia Pacific Cerebrospinal Fluid Management Market – Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Asia Pacific Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Asia Pacific Cerebrospinal Fluid Management Market Revenue, Country (US$ Mn), 2022 – 2030
Figure 7. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
Figure 8. CSF Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Ventriculoperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Ventriculoatrial Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Ventriculopleural Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Lumboperitoneal Shunts: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. CSF Drainage Systems: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. External Ventricular Drainage (EVD) Systems: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Lumbar Drainage (LD) Systems: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Asia Pacific Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
Figure 17. Hospitals: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Clinics: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Ambulatory Surgical Centers: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: Asia Pacific Cerebrospinal Fluid Management Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Asia Pacific Cerebrospinal Fluid Management Market, by Key Country- Revenue (2022) ($Mn)
Figure 22. Asia Pacific Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
Figure 23. China: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 24. Japan: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 25. India: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. Australia: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Korea: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Asia Pacific: Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies in The Asia Pacific Cerebrospinal Fluid Management Market, 2020-2023
The List of Companies – Asia Pacific Cerebrospinal Fluid Management Market
o B. Braun SE
o Integra LifeSciences Holdings Corp
o Medtronic Plc
o Natus Medical Inc
o Spiegelberg GmbH & Co KG
You must be logged in to post a review.
Reviews
There are no reviews yet.